Statistics for Pretreatment Pan-Immune-Inflammation Value Efficiently Predicts Survival Outcomes in Glioblastoma Multiforme Patients Receiving Radiotherapy and Temozolomide

Total visits

views
Pretreatment Pan-Immune-Inflammation Value Efficiently Predicts Survival Outcomes in Glioblastoma Multiforme Patients Receiving Radiotherapy and Temozolomide 0

Total visits per month

views
February 2026 0
March 2026 0
April 2026 0
May 2026 0
June 2026 0
July 2026 0
August 2026 0

File Visits

views
124.pdf 1